Last updated on August 2018

ADYNOVATE Drug Use-Results Survey

Brief description of study

The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients:

  1. Unexpected adverse drug reactions
  2. Occurrence of adverse drug reactions in the actual clinical use
  3. Factors that may affect safety and efficacy
  4. Occurrence of Factor VIII inhibitor development in patients with coagulation factor VIII deficiency (hereinafter hemophilia A)
  5. Safety and efficacy for hemophilia A patients who received routine prophylactic therapy and on-demand therapy

Clinical Study Identifier: NCT03169972

Contact Investigators or Research Sites near you

Start Over

Claudia Schwarz, PhD

Matsuyama City, Japan
Matsuyama City, Japan
  Connect »

Claudia Schwarz, PhD

Toon City
Toon City, Japan
  Connect »